The lower rating came from HSBC, which cited too much optimism around its new weight-loss pill, and the strength of Novo ...

Industry Veteran Brings 30 Years of Experience in Finance, Strategy and Operations WALTHAM, Mass., April 28, 2025 (GLOBE ...

Fintel reports that on April 28, 2025, HSBC downgraded their outlook for Eli Lilly and (NYSE:LLY) from Buy to Reduce. Analyst ...

In an exclusive to ADWEEK, ESPN announced Eli Lilly and Company as the presenting sponsor of the summit, which first launched ...

With its 2-star rating, we believe Lilly stock is overvalued compared with our long-term fair value estimate of $650 per ...

IBM is making a major bet on America's tech future. The company announced plans on Monday to invest $150 billion across the ...

As the tariff wars continue to unfold, the markets are attempting to kick off the week with gains as the latest slew of tech ...

The 13-year-old daughter of a Jefferies analyst asked about the effect of GLP-1 oral medications during PepsiCo’s most recent ...

(Reuters) -U.S. corporations have been ramping up their security spending, but following the murder of UnitedHealth (NYSE: ...

Novo Nordisk has launched its popular weight-loss drug Wegovy in Thailand, marking its first entry into the Southeast Asian ...

Mounjaro, the new weight loss drug, is gaining popularity in India for its rapid results. Patients report better appetite control, blood sugar management, and significant weight loss.

Health care is a human right that all Americans, regardless of income, are entitled to and they deserve the best health care that our country can provide.” Under this legislation, Medicare would ...